Agilent Technologies, Inc. (A) vs Moderna, Inc. (MRNA)
A leads on 7 of 10 compared metrics.
A side-by-side comparison of Agilent Technologies, Inc. and Moderna, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 6, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — A vs MRNA
growth of $100 · last 8yA +81.2%MRNA +332.7%MRNA compounded faster
A MRNA
A vs MRNA: by the numbers
- •A is the larger company ($36.89B vs $32.46B market cap).
- •A is profitable (19.55% net margin) while MRNA runs a net loss (-143.55%).
- •A grew revenue faster over the past five years (4.45% vs -2.60% CAGR).
- •A pays a dividend (0.78% yield) while MRNA does not currently pay one.
Which is better, A or MRNA?
Metric tally: A 7 · MRNA 3It depends on what you're optimizing for:
GrowthA(faster 5Y revenue CAGR)
QualityA(higher ROIC)
Metrics side by side
Valuation
| Metric | A | MRNA |
|---|---|---|
| P/E ratio | 26.24 | — |
| Forward P/E | 21.58 | — |
| P/S ratio | 5.13● | 14.16 |
| P/B ratio | 5.21 | 4.25● |
| PEG ratio | 9.44 | — |
| EV / EBITDA | 21.10 | — |
| FCF yield | 3.38% | — |
Profitability
| Metric | A | MRNA |
|---|---|---|
| Gross margin | 53.00% | 55.35%● |
| Operating margin | 21.50%● | -153.35% |
| Net margin | 19.55%● | -143.55% |
| ROE | 19.85%● | -43.12% |
| ROIC | 12.57%● | -29.70% |
Dividends
| Metric | A | MRNA |
|---|---|---|
| Dividend yield | 0.78% | — |
| Payout ratio | 22.22% | — |
Growth (annualized)
| Metric | A | MRNA |
|---|---|---|
| Revenue CAGR (5Y) | 4.45%● | -2.60% |
| EPS CAGR (5Y) | 14.52% | — |
| FCF CAGR (5Y) | 0.05% | 126.92%● |
| Total return CAGR (5Y) | -1.96%● | -19.18% |
Frequently asked
- Which is better, A or MRNA?
- It depends on your goal. growth: A (faster 5Y revenue CAGR); quality: A (higher ROIC). Across all compared metrics, A leads 7 to 3.
- Which has grown faster, A or MRNA?
- Over the past five years, A grew revenue faster — A at a 4.45% CAGR versus MRNA at -2.60%.
- Does A or MRNA pay a bigger dividend?
- A pays a dividend (0.78% yield) while MRNA does not currently pay one.
- Is A or MRNA more profitable?
- A runs the higher net margin — A at 19.55% versus MRNA at -143.55%.
- Which has been the better investment, A or MRNA?
- Over the past 5-year, A delivered the higher annualized total return — A at 12.22% versus MRNA at -19.18%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Agilent Technologies P/E ratioModerna P/E ratioAgilent Technologies dividend yieldModerna dividend yieldAgilent Technologies ROEModerna ROEAgilent Technologies operating marginModerna operating marginAgilent Technologies revenue growthModerna revenue growthAgilent Technologies free cash flowModerna free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 6, 2026.